Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Smith

Showing results (241-250 of 270) with videos related to

Pageof 27
Sort By:
JAMA Network Open|September 17, 2021
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemChristopher Michael Warren, Theo Thomas Snow, Alexandra S Lee, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
Oncoimmunology|May 1, 2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanomaJorge D Oldan, Benjamin C Giglio, Eric Smith, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Blood Advances|June 12, 2023
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myelomaDae Hyun Lee, Abhishek Kumar, Turab Mohammed, et al.
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Spine|May 11, 2006
Reliability of a novel classification system for thoracolumbar injuries: the Thoracolumbar Injury Severity ScoreAlexander R Vaccaro, Eli M Baron, James Sanfilippo, et al.
Science Translational Medicine|November 9, 2022
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma modelsJoyce Wei, Welby Montalvo-Ortiz, Lola Yu, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung CancerDamien Vasseur, Shin Saito, Gunsagar S Gulati, et al.
Pageof 27

Showing results (241-250 of 270) with videos related to

Sort By:
Pageof 27
JAMA Network Open|September 17, 2021
Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health SystemChristopher Michael Warren, Theo Thomas Snow, Alexandra S Lee, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
Oncoimmunology|May 1, 2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanomaJorge D Oldan, Benjamin C Giglio, Eric Smith, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Blood Advances|June 12, 2023
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myelomaDae Hyun Lee, Abhishek Kumar, Turab Mohammed, et al.
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Spine|May 11, 2006
Reliability of a novel classification system for thoracolumbar injuries: the Thoracolumbar Injury Severity ScoreAlexander R Vaccaro, Eli M Baron, James Sanfilippo, et al.
Science Translational Medicine|November 9, 2022
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma modelsJoyce Wei, Welby Montalvo-Ortiz, Lola Yu, et al.
Blood|December 9, 2024
Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomesCiara L Freeman, Jerald Noble, Meghan Menges, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung CancerDamien Vasseur, Shin Saito, Gunsagar S Gulati, et al.
Pageof 27